Not recruitingEUCTR 2019-004740-30
Cannabidiol for reducing drinking in Addiction and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.
This historical record does not confirm current site availability.
Historical research recordFrance
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Bron and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Centre Hospitalier Le Vinatier
- Sponsor type
- Unknown or unclear
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2019-004740-30
- Official title
Show the full official title
Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bron · Lille Cedex · Lyon Cedex 04
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre Hospitalier Le Vinatier.
Is this study still recruiting?
The registry lists this study as not recruiting.
